The Verastem stock price fell by -66.17% on the last day (Friday, 24th May 2024) from $12.18 to $4.12. During the last trading day the stock fluctuated 30.60% from a day low at $4.02 to a day high of $5.25. The price has been going up and down for this period, and there has been a -65.23% loss for the last 2 weeks.BOSTON, May 23, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2 clinical trial evaluating avutometinib plus defactinib in combination with gemcitabine and Nab ...Verastem Oncology VSTM announced positive interim safety and efficacy data from the dose level 1 cohort of its early to mid-stage study evaluating avutometinib and …Verastem Oncology aims to change that by relentlessly pursuing RAS-targeted treatment combinations with avutometinib. We’re driven to develop treatments that give patients more choices and the possibility of better outcomes. Verastem Oncology (NASDAQ: VSTM) is a biopharmaceutical company focused on exploring the unexplored to give patients ...Track PERASO INC (PRSO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAbout Verastem Oncology. Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that ...See Verastem, Inc. (VSTM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Verastem Oncology is currently conducting clinical trials with its RAF/MEK clamp avutometinib in RAS pathway-driven tumors as part of its (Raf And Mek Program). RAMP 301 is a Phase 3 confirmatory ...Investors: Ajay Munshi Vice President, Corporate Development +1 781-469-1579 [email protected] Sherri Spear Argot Partners +1 212-600-1902 [email protected] Media: Lisa Buffington ...At Verastem Oncology, we're on a mission to make sure no patient ever has to hear that news. We embrace the power of partnership and collaboration to develop novel cancer therapies. It's through these collaborations that we'll bring hope to patients with RAS pathway-driven cancers. Purposeful. Unwavering. Influential. Insightful.Track Versus Systems Inc (VS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Women’s Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs. March 11, 2024Verastem, Inc. stock has split one time since the company went public. The most recent was a 833333-for-10000000 split on 06/01/2023. View VSTM's stock split history here .Mr Paterson joined Verastem Oncology in 2011 and was its President and Chief Operating Officer prior to becoming President and Chief Executive Officer in 2023. He has more than 30 years of experience at healthcare and biotechnology companies, including leadership roles as Chief Business Officer (CBO), Chief Operating Officer (COO) and Chief ...Summary. Verastem's stock plummeted after updates showed reduced efficacy in cancer treatment trials, causing a reassessment of strategy. Updated clinical …Verastem, Inc. (VSTM) Follow. 11.85 -0.07 (-0.59%) At close: May 10 at 4:00 PM EDT. 11.50 -0.35 (-2.95%) After hours: May 10 at 6:50 PM EDT. All. News. Press Releases. …Verastem, Inc. (VSTM) Company Bio. Verastem, Inc. focuses on discovering and developing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. The company was founded in 2010 and is based in Needham, Massachusetts.Verastem Inc. analyst ratings, historical stock prices, earnings estimates & actuals. VSTM updated stock price target summary.Verastem has a market cap or net worth of $305.43 million. The enterprise value is $237.35 million. Market Cap. 305.43M. Enterprise Value. 237.35M.BOSTON, March 05, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients, today announced that preclinical data will be presented in ...Stocktwits provides real-time stock, crypto & international market data to keep you up-to-date. Find top news headlines, discover your next trade idea, share & gain insights from traders and investors from around the world, build a watchlist, buy US stocks, & create and manage your portfolio.Track Beam Global (BEEM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsLatest VERASTEM (VSTM) stock news, Verastem, Inc., operating as Verastem Oncology, is a biopharmaceutical company focusing on developin... Close. Discover the power of a Real-Time Financial News Database! ... Import your watchlist from Stocktwits and get a realtime overview of all news articles published regarding your favorite symbols.We would like to show you a description here but the site won't allow us.For many patients with difficult-to-treat cancers, the options have been few. Verastem Oncology aims to change that by pursuing RAS pathway-targeted treatment combinations with avutometinib (VS-6766). Find out more about our clinical trials here. FIND A TRIAL. Verastem-Sponsored Trials Investigator-Sponsored Trials.At Verastem Oncology, we're on a mission to make sure no patient ever has to hear that news. We embrace the power of partnership and collaboration to develop novel cancer therapies. It's through these collaborations that we'll bring hope to patients with RAS pathway-driven cancers. Purposeful. Unwavering. Influential. Insightful.An outbreak at local lockups could overwhelm area hospitals. Details emerging about conditions at a Massachusetts jail—one of the 637 facilities nationwide that US Immigration and ...Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell ...Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...Verastem, Inc. (VSTM) Follow. 4.1200 -8.0600 (-66.17%) At close: 4:00 PM EDT. 4.1703 +0.05 (+1.22%) After hours: 5:08 PM EDT. Conversations. Community Insights. MRUS …Web-based application Pixolu helps you find images by their similarity to each other. Enter a search term and Pixolu searches the image indexes of Google, Yahoo, and Flickr. Once P...TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comVeru is a biopharmaceutical company focused on developing novel medicines for high-quality weight loss, breast cancer, and viral related ARDSGFH375/VS-7375. GFH375/VS-7375 is an orally bioavailable, potent and selective small molecule KRAS G12D (ON/OFF) inhibitor. Preclinical models demonstrate strong tumor regression as a single agent and support approaches in combination with Verastem Oncology’s RAF/MEK clamp avutometinib as well as other rational combinations across …Track VERSES Technologies Inc - Ordinary Shares - Class A (Sub Voting) (VRSSF) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem will retain all rights to duvelisib outside of Japan.” The company has indicated another ex-US partnership by the end of 2018 as seen below. ... The skilled StockTwits user and VSTM ...Key Events. Mountain. Loading Chart for VSTM. 9/21 12:03 PM. Previous Close 12.1800. Open 4.7300. Bid 4.0500 x 700. Ask 5.1500 x 200. Day's Range 4.0200 - 5.2500. 52 …Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), ANI Pharmaceuticals (ANIP) and Argenx Se (ARGX) May 13, 2024TipRanks. RBC Capital Sticks to Their Buy Rating for Verastem (VSTM ...Track Viasat, Inc. (VSAT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack OrganiGram Holdings Inc. (OGI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsSource: Verastem, Inc. Verastem Oncology: Brian Sullivan, +1 781-469-1636 Senior Director, Corporate Development [email protected] or Media: FleishmanHillard Adam Silverstein, +1 917-697-9313 [email protected] or Investors: Argot Partners Joseph Rayne, +1 617-340-6075 [email protected] Oncology, a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the grant of stock options to purchase 22,500 shares of its common stock and the grant of 15,000 restricted stock units to one new employee. The stock options have an exercise price equal to $0.87 per share, the closing ...Fintel reports that on June 27, 2023, Truist Securities reiterated coverage of Verastem ( NASDAQ:VSTM) with a Buy recommendation. Analyst Price Forecast Suggests 393.85% Upside. As of June 2, 2023 ...About Verastem Oncology. Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that ...VSTM Stock 12 Months Forecast. $31.67. (187.91% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Verastem in the last 3 months. The average price target is $31.67 with a high forecast of $36.00 and a low forecast of $27.00. The average price target represents a 187.91% change from the last price of $11.00.Goldman Sachs Adjusts Price Target on DISH Network to $3 From $6, Maintains Neutral Rating. Nov. 09. MT. Deutsche Bank Cuts DISH Network Price Target to $10 From $15, Maintains Buy Rating. Nov. 08. MT. UBS Cuts DISH Network Price Target to $4 From $9, Maintains Neutral Rating. Nov. 07.Verastem Stock Forecast. All Analysts Top Analysts Stock Price Forecast. The 7 analysts with 12-month price forecasts for Verastem stock have an average target of 28.79, with a low estimate of 17.5 and a high estimate of 36. The average target predicts an increase of 598.79% from the current stock price of 4.12. Analyst Consensus: Strong Buy. Target …By: Brian Stuglik, CEO, Verastem Oncology. Over the past year, those of us working in pharmaceutical oncology R&D have watched with awe as industry colleagues worked together to speed vaccinations for COVID-19 from the lab to patients’ arms in record time. Breakthroughs in cancer research, typically don’t happen that quickly.DVAXDynavax Technologies Corporation. 11.88. +3.66%. Find the latest Curis, Inc. (CRIS) stock quote, history, news and other vital information to help you with your stock trading and investing.Track Microstrategy Inc. (MSTR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology is currently evaluating the efficacy and safety of VS-6766 alone and in combination with defactinib in the registration-directed Phase 2 RAMP 201 (Raf And Mek Program) (ENGOTov60 ...Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...Comparatively, 88.4% of Verastem shares are held by institutional investors. 7.7% of Vanda Pharmaceuticals shares are held by company insiders. Comparatively, 2.2% of Verastem shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for ...NasdaqCM - Nasdaq Real Time Price • USD. Verastem, Inc. (VSTM) Follow. 4.1200 -8.0600 (-66.17%) At close: 4:00 PM EDT. 4.1703 +0.05 (+1.22%) After hours: 5:08 PM EDT. Conversations. Community ...Track Visium Technologies Inc (VISM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology has established clinical collaborations with Amgen and Mirati to evaluate LUMAKRAS™ (sotorasib) in combination with avutometinib and defactinib and KRAZATI™ (adagrasib) in combination with avutometinib in KRAS G12C mutant NSCLC as part of the RAMP 203 (NCT05074810) and RAMP 204 (NCT05375994) trials, …Mr Paterson joined Verastem Oncology in 2011 and was its President and Chief Operating Officer prior to becoming President and Chief Executive Officer in 2023. He has more than 30 years of experience at healthcare and biotechnology companies, including leadership roles as Chief Business Officer (CBO), Chief Operating Officer (COO) and Chief .... Verastem stock resides in the small cap universe with a market cap Verastem Oncology (Nasdaq: VSTM) is a de NasdaqCM - Nasdaq Real Time Price • USD. Verastem, Inc. (VSTM) Follow. 4.1200 -8.0600 (-66.17%) At close: 4:00 PM EDT. 4.1703 +0.05 (+1.22%) After hours: 5:08 PM EDT. Conversations. Community ... Verastem Oncology Announces Initiation of Track Amesite Inc (AMST) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Verastem Oncology, a biopharmaceutical company committed to a...
Continue Reading